Published in J Clin Microbiol on August 01, 1997
Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin Microbiol Rev (1999) 5.84
The ins and outs of DNA fingerprinting the infectious fungi. Clin Microbiol Rev (2000) 2.95
Phenotypic and molecular characterization of Candida nivariensis sp. nov., a possible new opportunistic fungus. J Clin Microbiol (2005) 2.52
Multiplex PCR using internal transcribed spacer 1 and 2 regions for rapid detection and identification of yeast strains. J Clin Microbiol (2001) 1.79
Identification of Candida spp. by randomly amplified polymorphic DNA analysis and differentiation between Candida albicans and Candida dubliniensis by direct PCR methods. J Clin Microbiol (2003) 1.27
High-frequency, in vitro reversible switching of Candida lusitaniae clinical isolates from amphotericin B susceptibility to resistance. Antimicrob Agents Chemother (1999) 1.01
Antifungal effects of lysozyme and lactoferrin against genetically similar, sequential Candida albicans isolates from a human immunodeficiency virus-infected southern Chinese cohort. J Clin Microbiol (2001) 0.99
Stable phenotypic resistance of Candida species to amphotericin B conferred by preexposure to subinhibitory levels of azoles. J Clin Microbiol (1998) 0.94
Oral colonization, phenotypic, and genotypic profiles of Candida species in irradiated, dentate, xerostomic nasopharyngeal carcinoma survivors. J Clin Microbiol (2000) 0.90
PCR assay for species-specific identification of Bacteroides thetaiotaomicron. J Clin Microbiol (2000) 0.90
Molecular characterization of Yarrowia lipolytica and Candida zeylanoides isolated from poultry. Appl Environ Microbiol (2000) 0.85
Candidiasis during pregnancy may result from isogenic commensal strains. Infect Dis Obstet Gynecol (2001) 0.83
Differentiation of Aspergillus niger by random amplification of polymorphic DNA. J Ind Microbiol Biotechnol (2008) 0.80
Performance of optimized McRAPD in identification of 9 yeast species frequently isolated from patient samples: potential for automation. BMC Microbiol (2009) 0.79
Identification of Streptococcus sanguinis with a PCR-generated species-specific DNA probe. J Clin Microbiol (2003) 0.78
Identification and Antifungal Susceptibility Testing of Candida Species: A Comparison of Vitek-2 System with Conventional and Molecular Methods. J Glob Infect Dis (2016) 0.77
Budding off: bringing functional genomics to Candida albicans. Brief Funct Genomics (2015) 0.75
DNA polymorphisms amplified by arbitrary primers are useful as genetic markers. Nucleic Acids Res (1990) 47.84
Application of DNA typing methods to epidemiology and taxonomy of Candida species. J Clin Microbiol (1987) 13.21
Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System. Am J Med (1991) 9.11
Strain and species identification by restriction fragment length polymorphisms in the ribosomal DNA repeat of Candida species. J Bacteriol (1987) 6.71
CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. J Clin Microbiol (1994) 6.67
Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis. Clin Infect Dis (1994) 5.44
New and emerging yeast pathogens. Clin Microbiol Rev (1995) 4.75
Importance of Candida species other than C. albicans as pathogens in oncology patients. Clin Infect Dis (1995) 4.35
Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis. J Clin Microbiol (1994) 4.27
Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: frequency, characteristics, and evaluation of factors influencing outcome. Rev Infect Dis (1989) 4.01
Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection. J Clin Microbiol (1994) 3.51
Molecular probes for diagnosis of fungal infections. J Clin Microbiol (1995) 3.29
Genotypic identification and characterization of species and strains within the genus Candida by using random amplified polymorphic DNA. J Clin Microbiol (1992) 3.27
Application of CHROMagar Candida for rapid screening of clinical specimens for Candida albicans, Candida tropicalis, Candida krusei, and Candida (Torulopsis) glabrata. J Clin Microbiol (1996) 3.23
Chromosomal rearrangements associated with morphological mutants provide a means for genetic variation of Candida albicans. J Bacteriol (1990) 3.17
Candida lusitaniae: frequency of recovery, colonization, infection, and amphotericin B resistance. J Clin Microbiol (1984) 2.99
Variation of electrophoretic karyotypes among clinical isolates of Candida albicans. J Clin Microbiol (1988) 2.92
Comparison of updated Vitek Yeast Biochemical Card and API 20C yeast identification systems. J Clin Microbiol (1994) 2.54
Evaluation of the updated Vitek yeast identification data base. J Clin Microbiol (1990) 2.45
Laboratory diagnosis of invasive candidiasis. Clin Microbiol Rev (1990) 2.44
Amphotericin B-resistant yeast infection in severely immunocompromised patients. Am J Med (1988) 2.44
Identification of Candida species by PCR and restriction fragment length polymorphism analysis of intergenic spacer regions of ribosomal DNA. J Clin Microbiol (1995) 2.40
Application of DNA typing methods to Candida albicans epidemiology and correlations with phenotype. Rev Infect Dis (1990) 2.30
Current trends in immunodiagnosis of candidiasis and aspergillosis. Rev Infect Dis (1984) 2.22
Comparison of restriction enzyme analysis and pulsed-field gradient gel electrophoresis as typing systems for Candida albicans. J Clin Microbiol (1991) 2.12
Reproducibility of random amplified polymorphic DNA (RAPD) analysis among laboratories. PCR Methods Appl (1993) 1.97
Genotype and phenotype of oral Candida albicans from patients infected with the human immunodeficiency virus. Microbiology (1994) 1.96
Fatal disseminated candidiasis due to amphotericin-B-resistant Candida guilliermondii. Ann Intern Med (1985) 1.84
Direct identification and recognition of yeast species from clinical material by using albicans ID and CHROMagar Candida plates. J Clin Microbiol (1996) 1.83
Molecular genetic approaches to identification, epidemiology and taxonomy of non-albicans Candida species. J Med Microbiol (1996) 1.81
Identification of clinical strains of Candida albicans by DNA fingerprinting with the polymerase chain reaction. Mycoses (1994) 1.67
Rapid identification of Candida species by DNA fingerprinting with PCR. J Clin Microbiol (1996) 1.52
Comparison of restriction enzyme analysis versus pulsed-field gradient gel electrophoresis as a typing system for Torulopsis glabrata and Candida species other than C. albicans. J Clin Microbiol (1993) 1.49
Ability of RapID Yeast Plus System to identify 304 clinically significant yeasts within 5 hours. J Clin Microbiol (1996) 1.41
Comparison of PCR fingerprinting, by random amplification of polymorphic DNA, with other molecular typing methods for Candida albicans. J Gen Microbiol (1993) 1.37
Comparison of the new API Candida system to the ID 32C system for identification of clinically important yeast species. J Clin Microbiol (1996) 1.35
Rapid presumptive identification of medically relevant yeasts to the species level by polymerase chain reaction and restriction enzyme analysis. J Med Vet Mycol (1994) 1.30
Screening protocol for Torulopsis (Candida) glabrata. J Clin Microbiol (1996) 1.27
Use of random amplified polymorphic DNA as a typing method for Candida albicans in epidemiological surveillance of a burn unit. J Clin Microbiol (1995) 1.27
Origin of differences in susceptibility of Candida krusei to azole antifungal agents. Mycoses (1995) 1.23
Typing of Candida krusei clinical isolates by restriction endonuclease analysis and hybridization with CkF1,2 DNA probe. J Clin Microbiol (1994) 1.16
Methods for the genetics and molecular biology of Candida albicans. Anal Biochem (1988) 1.11
Detection of microbial nucleic acids for diagnostic purposes. Annu Rev Med (1992) 1.09
Strain variation among and antifungal susceptibilities of isolates of Candida krusei. J Clin Microbiol (1996) 1.06
Phenotypic and genotypic characterization of unusual vaginal isolates of Candida albicans from Africa. J Clin Microbiol (1995) 1.05
Comparison of four DNA-based methods for strain delineation of Candida lusitaniae. J Clin Microbiol (1995) 1.02
Disseminated candidiasis caused by four different Candida species. Arch Pathol Lab Med (1981) 1.02
PCR-mediated genotyping of Candida albicans strains from bone marrow transplant patients. Bone Marrow Transplant (1994) 1.00
Invasive Candida guilliermondii infection: in vitro susceptibility studies and molecular analysis. Bone Marrow Transplant (1995) 0.99
Evaluation of CHROMagar Candida plates. J Clin Microbiol (1996) 0.96
Genetic dissimilarity of two fluconazole-resistant Candida albicans strains causing meningitis and oral candidiasis in the same AIDS patient. J Clin Microbiol (1996) 0.96
Torulopsis glabrata vaginitis. Obstet Gynecol (1995) 0.87
Emerging opportunists. Infect Dis Clin North Am (1989) 0.86
Variations in chromosome size and organization in Candida albicans and Candida stellatoidea. Trends Microbiol (1993) 0.86
SCH 51048, a new antifungal triazole active against hematogenous Candida krusei infections in neutropenic mice. Antimicrob Agents Chemother (1995) 0.85
High-GC primers are useful in RAPD analysis of fungi. Curr Genet (1995) 0.81
Random amplified polymorphic DNA for strain delineation within Candida tropicalis. J Med Vet Mycol (1996) 0.79
An autopsy study of systemic fungal infections in patients with hematologic malignancies. Eur J Clin Microbiol Infect Dis (1995) 0.78
Intravenous catheter-associated Malassezia furfur fungemia. Am J Med (1987) 0.78
Molecular identification of Candida albicans. J Med Vet Mycol (1995) 0.77
[The changing pattern of Candida infections: different species and increased resistance]. Ned Tijdschr Geneeskd (1996) 0.76
Haplotype variation and linkage disequilibrium in 313 human genes. Science (2001) 8.52
Current methods in medical image segmentation. Annu Rev Biomed Eng (2000) 6.24
Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group. N Engl J Med (1997) 5.88
Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin Microbiol Rev (1999) 5.84
Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America. Clin Infect Dis (2000) 5.73
Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America. Clin Infect Dis (2000) 5.53
Urinary tract infection: self-reported incidence and associated costs. Ann Epidemiol (2000) 4.26
Detection of circulating candida enolase by immunoassay in patients with cancer and invasive candidiasis. N Engl J Med (1991) 4.20
Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial. Lancet (2005) 4.17
Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: frequency, characteristics, and evaluation of factors influencing outcome. Rev Infect Dis (1989) 4.01
Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis. Am J Obstet Gynecol (1985) 3.97
The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical study. Leukemia (2008) 3.69
Plasmid-associated hemolysin and aggregation substance production contribute to virulence in experimental enterococcal endocarditis. Antimicrob Agents Chemother (1993) 3.35
Design of organic molecules with large two-photon absorption cross sections. Science (1998) 3.27
Emerging role of lactobacilli in the control and maintenance of the vaginal bacterial microflora. Rev Infect Dis (1990) 3.19
In vitro activity of a new pneumocandin antifungal, L-743,872, against azole-susceptible and -resistant Candida species. Antimicrob Agents Chemother (1997) 3.17
Critical role of germ tube formation in the pathogenesis of candidal vaginitis. Infect Immun (1984) 3.07
DNA topoisomerase targets of the fluoroquinolones: a strategy for avoiding bacterial resistance. Proc Natl Acad Sci U S A (1997) 2.99
General method for cloning Neurospora crassa nuclear genes by complementation of mutants. Mol Cell Biol (1985) 2.85
Search for a resonance decaying into WZ boson pairs in pp collisions. Phys Rev Lett (2010) 2.83
The vaginal microbiome: new information about genital tract flora using molecular based techniques. BJOG (2011) 2.41
A protein required for splicing group I introns in Neurospora mitochondria is mitochondrial tyrosyl-tRNA synthetase or a derivative thereof. Cell (1987) 2.37
Fluoroquinolone action against mycobacteria: effects of C-8 substituents on growth, survival, and resistance. Antimicrob Agents Chemother (1998) 2.35
Two-Photon Fluorescence Excitation Cross Sections of Biomolecular Probes from 690 to 960 nm. Appl Opt (1998) 2.31
Adherence of Candida albicans to human vaginal and buccal epithelial cells. J Infect Dis (1981) 2.27
Randomised clinical trial: herbal extract HMPL-004 in active ulcerative colitis - a double-blind comparison with sustained release mesalazine. Aliment Pharmacol Ther (2010) 2.20
Prospective multicenter surveillance study of funguria in hospitalized patients. The National Institute for Allergy and Infectious Diseases (NIAID) Mycoses Study Group. Clin Infect Dis (2000) 2.15
Morbidity and mortality in Cushing's disease: an epidemiological approach. Clin Endocrinol (Oxf) (1994) 2.14
Nosocomial Pseudomonas cepacia infection associated with chlorhexidine contamination. Am J Med (1982) 2.14
A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. National Institute of Allergy and Infectious Diseases Mycoses Study Group. Clin Infect Dis (1999) 2.14
Comparison of restriction enzyme analysis and pulsed-field gradient gel electrophoresis as typing systems for Candida albicans. J Clin Microbiol (1991) 2.12
Candida-specific cell-mediated immunity is demonstrable in mice with experimental vaginal candidiasis. Infect Immun (1993) 2.08
Validity of the vaginal gram stain for the diagnosis of bacterial vaginosis. Obstet Gynecol (1996) 2.07
Alopecia associated with fluconazole therapy. Ann Intern Med (1995) 2.05
First observation of PeV-energy neutrinos with IceCube. Phys Rev Lett (2013) 2.00
Expression of complement receptors 1 and 2 on follicular dendritic cells is necessary for the generation of a strong antigen-specific IgG response. J Immunol (1998) 1.96
Immunopathogenesis of recurrent vulvovaginal candidiasis. Clin Microbiol Rev (1996) 1.90
An analysis of relationships among plant community phenology and seasonal metrics of Normalized Difference Vegetation Index in the northern part of the monsoon region of China. Int J Biometeorol (2001) 1.89
Risk factors for second urinary tract infection among college women. Am J Epidemiol (2000) 1.88
Killing of Staphylococcus aureus by C-8-methoxy fluoroquinolones. Antimicrob Agents Chemother (1998) 1.86
T lymphocytes and macrophages, but not motile spermatozoa, are a significant source of human immunodeficiency virus in semen. J Infect Dis (1997) 1.85
Multiphoton-excited visible emission by serotonin solutions. Photochem Photobiol (1997) 1.85
Candida-specific Th1-type responsiveness in mice with experimental vaginal candidiasis. Infect Immun (1993) 1.84
Nosocomial acquisition of Candida albicans: an epidemiologic study. J Infect Dis (1993) 1.81
Fluid wall shear stress measurements in a model of the human abdominal aorta: oscillatory behavior and relationship to atherosclerosis. Atherosclerosis (1994) 1.81
Recurrent vulvovaginal candidiasis. A prospective study of the efficacy of maintenance ketoconazole therapy. N Engl J Med (1986) 1.81
The use of propranolol in the treatment of infantile haemangiomas: an update on potential mechanisms of action. Br J Dermatol (2014) 1.80
Candiduria: a randomized, double-blind study of treatment with fluconazole and placebo. The National Institute of Allergy and Infectious Diseases (NIAID) Mycoses Study Group. Clin Infect Dis (2000) 1.80
Renin-stimulated TGF-beta1 expression is regulated by a mitogen-activated protein kinase in mesangial cells. Kidney Int (2007) 1.76
Epidemiology and molecular basis of penicillin-resistant Neisseria meningitidis in Spain: a 5-year history (1985-1989). Clin Infect Dis (1992) 1.73
Liver abscess caused by Streptococcus milleri. Rev Infect Dis (1989) 1.71
Torulopsis glabrata vaginitis: clinical aspects and susceptibility to antifungal agents. Obstet Gynecol (1990) 1.69
Effects of preinduced Candida-specific systemic cell-mediated immunity on experimental vaginal candidiasis. Infect Immun (1994) 1.68
Development and verification of fingerprinting probes for Candida glabrata. Microbiology (1997) 1.67
Vulvovaginal candidiasis--what we do and do not know. Ann Intern Med (1984) 1.67
Management of recurrent vulvovaginal candidiasis with intermittent ketoconazole prophylaxis. Obstet Gynecol (1985) 1.64
Single-molecule detection by two-photon-excited fluorescence. Opt Lett (1995) 1.64
Field performance of transgenic elite commercial hybrid rice expressing bacillus thuringiensis delta-endotoxin. Nat Biotechnol (2000) 1.62
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Polymorphonuclear leucocyte function in Behçet's disease. J Clin Pathol (1977) 1.59
Weekly fluconazole for the prevention of mucosal candidiasis in women with HIV infection. A randomized, double-blind, placebo-controlled trial. Terry Beirn Community Programs for Clinical Research on AIDS. Ann Intern Med (1997) 1.58
Micafungin: a new echinocandin. Clin Infect Dis (2006) 1.58
Nosocomial Candida glabrata colonization: an epidemiologic study. J Clin Microbiol (1998) 1.57
Circulating CD4 and CD8 T cells have little impact on host defense against experimental vaginal candidiasis. Infect Immun (1995) 1.56
Reduced susceptibility in laboratory-selected mutants of Aspergillus fumigatus to itraconazole due to decreased intracellular accumulation of the antifungal agent. Int J Antimicrob Agents (1999) 1.55
Comparison of restriction enzyme analysis versus pulsed-field gradient gel electrophoresis as a typing system for Torulopsis glabrata and Candida species other than C. albicans. J Clin Microbiol (1993) 1.49
Need for alternative trial designs and evaluation strategies for therapeutic studies of invasive mycoses. Clin Infect Dis (2001) 1.48
Mice immunized by primary vaginal Candida albicans infection develop acquired vaginal mucosal immunity. Infect Immun (1995) 1.48
Ventilatory response of the sleeping newborn to CO2 during normoxic rebreathing. J Appl Physiol (1985) (1991) 1.47
Experimental chronic vaginal candidosis in rats. Sabouraudia (1985) 1.46
Sonic hedgehog expression correlates with fundic gland differentiation in the adult gastrointestinal tract. Gut (2002) 1.46
Systemic cell-mediated immune reactivity in women with recurrent vulvovaginal candidiasis. J Infect Dis (1993) 1.45
Epidemiology of recurrent vulvovaginal candidiasis: identification and strain differentiation of Candida albicans. J Infect Dis (1986) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Simplified percutaneous mitral valvuloplasty with the Inoue balloon. Eur Heart J (1998) 1.41
Bacterial adherence in the pathogenesis of urinary tract infection: a review. Rev Infect Dis (1987) 1.41
Additive blockade of beta 2-integrin adhesion of eosinophils by salmeterol and fluticasone propionate. Eur Respir J (2004) 1.40
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Comparative in vitro activity of antimycotic agents against pathogenic vaginal yeast isolates. J Med Vet Mycol (1994) 1.38
Clinical, microbiological, and biochemical factors in recurrent bacterial vaginosis. J Clin Microbiol (1992) 1.38
A murine model of Candida glabrata vaginitis. J Infect Dis (1996) 1.35
Growth inhibition of Candida albicans by human vaginal epithelial cells. J Infect Dis (2001) 1.35
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Mitochondrial plasmids of Neurospora: integration into mitochondrial DNA and evidence for reverse transcription in mitochondria. Cell (1986) 1.33
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Organization of uroplakin subunits: transmembrane topology, pair formation and plaque composition. Biochem J (2001) 1.31
Nosocomial acquisition of Candida parapsilosis: an epidemiologic study. Am J Med (1993) 1.31
Molecular cloning and characterization of the cys-3 regulatory gene of Neurospora crassa. Mol Cell Biol (1987) 1.31
Persistence of human immunodeficiency virus in semen after adding indinavir to combination antiretroviral therapy. Clin Infect Dis (1999) 1.28
Bacterial vaginosis: treatment with clindamycin cream versus oral metronidazole. Obstet Gynecol (1992) 1.28
Rapid growth of Acanthamoeba in defined media; induction of encystment by glucose-acetate starvation. J Protozool (1980) 1.28
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
The role of cell-mediated immunity in candidiasis. Trends Microbiol (1994) 1.27
Uroplakin I: a 27-kD protein associated with the asymmetric unit membrane of mammalian urothelium. J Cell Biol (1990) 1.27